LPAR5 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "LPAR5" in English language version.

Last modified: 04:24:46, 15 July 2025 (UTC)

Ref.Un. Ref.Website

Global rank English rank

5^th place

630^th place

326^th place

2^nd place

15^th place

8^th place

doi.org (Global: 2^nd place; English: 2^nd place)

"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23". Nature Genetics. 26 (3): 345–348. November 2000. doi:10.1038/81664. PMID 11062477. S2CID 38870810.
Lee DK, Nguyen T, Lynch KR, Cheng R, Vanti WB, Arkhitko O, et al. (September 2001). "Discovery and mapping of ten novel G protein-coupled receptor genes". Gene. 275 (1): 83–91. doi:10.1016/S0378-1119(01)00651-5. PMID 11574155.
Lee CW, Rivera R, Gardell S, Dubin AE, Chun J (August 2006). "GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5". The Journal of Biological Chemistry. 281 (33): 23589–23597. doi:10.1074/jbc.M603670200. PMID 16774927.
Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, Hansson S, et al. (August 2006). "Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes". The Journal of Pharmacology and Experimental Therapeutics. 318 (2): 619–628. doi:10.1124/jpet.105.098848. PMID 16651401. S2CID 5989815.
Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. (January 2010). "LPA receptors: subtypes and biological actions". Annual Review of Pharmacology and Toxicology. 50 (1): 157–186. doi:10.1146/annurev.pharmtox.010909.105753. PMID 20055701.

"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23". Nature Genetics. 26 (3): 345–348. November 2000. doi:10.1038/81664. PMID 11062477. S2CID 38870810.
Lee DK, Nguyen T, Lynch KR, Cheng R, Vanti WB, Arkhitko O, et al. (September 2001). "Discovery and mapping of ten novel G protein-coupled receptor genes". Gene. 275 (1): 83–91. doi:10.1016/S0378-1119(01)00651-5. PMID 11574155.
Lee CW, Rivera R, Gardell S, Dubin AE, Chun J (August 2006). "GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5". The Journal of Biological Chemistry. 281 (33): 23589–23597. doi:10.1074/jbc.M603670200. PMID 16774927.
Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, Hansson S, et al. (August 2006). "Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes". The Journal of Pharmacology and Experimental Therapeutics. 318 (2): 619–628. doi:10.1124/jpet.105.098848. PMID 16651401. S2CID 5989815.
Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. (January 2010). "LPA receptors: subtypes and biological actions". Annual Review of Pharmacology and Toxicology. 50 (1): 157–186. doi:10.1146/annurev.pharmtox.010909.105753. PMID 20055701.

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: GPR92 G protein-coupled receptor 92".

"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23". Nature Genetics. 26 (3): 345–348. November 2000. doi:10.1038/81664. PMID 11062477. S2CID 38870810.
Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, Hansson S, et al. (August 2006). "Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes". The Journal of Pharmacology and Experimental Therapeutics. 318 (2): 619–628. doi:10.1124/jpet.105.098848. PMID 16651401. S2CID 5989815.